145 related articles for article (PubMed ID: 23142425)
1. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.
Chung CJ; Pu YS; Shiue HS; Lee HL; Lin P; Yang HY; Su CT; Hsueh YM
Toxicol Lett; 2013 Jan; 216(1):16-22. PubMed ID: 23142425
[TBL] [Abstract][Full Text] [Related]
2. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM
Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728
[TBL] [Abstract][Full Text] [Related]
3. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
Brown PJ; Bedard LL; Reid KR; Petsikas D; Massey TE
Drug Metab Dispos; 2007 Nov; 35(11):2086-94. PubMed ID: 17717079
[TBL] [Abstract][Full Text] [Related]
4. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
Jalas JR; Ding X; Murphy SE
Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
[TBL] [Abstract][Full Text] [Related]
5. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
Chen G; Luo S; Kozlovich S; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
[TBL] [Abstract][Full Text] [Related]
6. Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
Wu CC; Su CT; Lee HL; Chung CJ; Huang CY; Pu YS; Lin P; Hsueh YM
J Urol; 2012 Nov; 188(5):1701-5. PubMed ID: 22998908
[TBL] [Abstract][Full Text] [Related]
7. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
Wiener D; Fang JL; Dossett N; Lazarus P
Cancer Res; 2004 Feb; 64(3):1190-6. PubMed ID: 14871856
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
9. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
[TBL] [Abstract][Full Text] [Related]
10. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
Carmella SG; Akerkar SA; Richie JP; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
Chiang HC; Wang CY; Lee HL; Tsou TC
Toxicol Appl Pharmacol; 2011 Jun; 253(2):145-52. PubMed ID: 21473878
[TBL] [Abstract][Full Text] [Related]
12. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
13. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC
Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809
[TBL] [Abstract][Full Text] [Related]
14. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.
Hecht SS; Chung FL; Richie JP; Akerkar SA; Borukhova A; Skowronski L; Carmella SG
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):877-84. PubMed ID: 8634661
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.
Lazarus P; Zheng Y; Runkle EA; Muscat JE; Wiener D
Pharmacogenet Genomics; 2005 Nov; 15(11):769-78. PubMed ID: 16220109
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of stereospecifically deuterated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) iastereomers and metabolism by A/J mouse lung microsomes and cytochrome p450 2A5.
Jalas JR; Hecht SS
Chem Res Toxicol; 2003 Jun; 16(6):782-93. PubMed ID: 12807362
[TBL] [Abstract][Full Text] [Related]
17. Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: stereoselective metabolism and tissue distribution.
Wu Z; Upadhyaya P; Carmella SG; Hecht SS; Zimmerman CL
Carcinogenesis; 2002 Jan; 23(1):171-9. PubMed ID: 11756238
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
Hecht SS; Carmella SG; Ye M; Le KA; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 2002 Jan; 62(1):129-34. PubMed ID: 11782369
[TBL] [Abstract][Full Text] [Related]
19. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
[TBL] [Abstract][Full Text] [Related]
20. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.
Kozlovich S; Chen G; Watson CJW; Blot WJ; Lazarus P
Drug Metab Dispos; 2019 Dec; 47(12):1388-1396. PubMed ID: 31578206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]